mRNA technologies have rapidly evolved into one of the most exciting and versatile classes of modern medicines, powering breakthroughs in vaccines and emerging therapies for metabolic, cardiovascular, ...

Antibody-based products are powerful research and therapeutic agents, but their discovery, development, and production require careful and repeated bioanalytical characterization. Mass photometry is ...

Mass Photometry (MP) and Macro Mass Photometry (MMP) are complementary, label-free techniques that analyze biomolecules and therapeutic vectors directly in solution with single-particle resolution.

Mass photometry is a powerful tool for assessing mRNA purity and integrity—but getting the most accurate and reliable results requires careful experimental design. This whitepaper presents a detailed ...

Refeyn, developer of pioneering mass photometry technology, expands its global adoption across contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs).

The US Pharmacopeia (USP) has recognized mass photometry as a key orthogonal method for characterizing its new adeno-associated virus (AAV) reference standards, as referenced in the draft general ...

Please acknowledge the SIP core facility ( RRID: SCR_018986) in publications, on posters, or in talks if you use any instruments in the SIP core facility. Please include SIP's RRID (RRID: SCR_018986) ...

To produce adeno-associated virus (AAV) therapeutics, researchers and technicians must monitor a range of critical quality attributes (CQAs). Currently, scientists use techniques such as analytical ...

Refeyn has introduced the MyMass™ mass photometer, a compact benchtop system designed to quickly evaluate biomolecular sample quality. The instrument measures purity, homogeneity, and oligomerization ...

Precision oncology company Orakl Oncology (Villejuif, France) has raised €11 million in seed funding to enable it to begin marketing its first two AI-powered products for oncology drug development, ...

Refeyn, the company behind pioneering mass photometry technology, announces that mass photometry has been recognized by the U.S. Pharmacopeia (USP)—and referenced in the new draft USP general chapter ...